Prostaglandin Levels in Pancreatic Cyst Fluid, Pancreatic Juice, and Resected Pancreatic Cysts
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 07-008538
Sponsor Protocol Number: 07-008538
About this study
The purpose of this study is to determine whether COX-2 enzyme activity in pancreatic cystic neoplasms is sufficient to justify a chemoprevention study.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Subject (or, if they are between 13 and 17 years of age, their parent or guardian) is able to give informed consent, and is not incarcerated;
- Subject is undergoing a clinically indicated endoscopic, percutaneous, or surgical procedure during which fluid will likely be obtained from a pancreas cystic structure or pancreatic fluid collection, OR
- Subject is undergoing a clinically indicated secretin-stimulated collection of pancreatic juice, with pancreatic juice collection from the duodenum via an endoscope or per-oral tube.
Exclusion Criteria:
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Mark Topazian, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available